Literature DB >> 9409275

Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.

A Laurila1, A Bloigu, S Näyhä, J Hassi, M Leinonen, P Saikku.   

Abstract

Chlamydia pneumoniae infection has been associated with coronary heart disease. To evaluate the mechanisms of this association, we studied whether chronic C. pneumoniae infection affects serum lipid values similarly to acute infections. Triglyceride, total and HDL cholesterol concentrations, and C. pneumoniae antibodies were measured from paired serum samples of 415 Finnish males taken 3 years apart. Chronic infection, defined as persistent IgG and IgA antibodies, was found in 20%, and the antibodies were negative (IgG < 32 and IgA < 16 in both samples) in 15% of the cases studied. The serum triglyceride and total cholesterol concentrations were higher in the subjects with a chronic C. pneumoniae infection than in the subjects with no antibodies (1.23 versus 1.03 mmol/L and 6.41 versus 6.31 mmol/L, respectively). The HDL cholesterol concentrations and the ratios of HDL cholesterol to total cholesterol were significantly decreased in the subjects with chronic infection (1.24 versus 1.36 mmol/L, P = .026; and 0.19 versus 0.22, P = .018, respectively). Chronic C. pneumoniae infection seems to be associated with a serum lipid profile considered to increase the risk of atherosclerosis. This finding supports the hypothesis that infections play a role in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409275     DOI: 10.1161/01.atv.17.11.2910

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

Review 1.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

3.  Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography.

Authors:  Jaro Karppinen; Mauno Kurunlahti; Simo Taimela; Marianne Haapea; Heikki Vanharanta; Osmo Tervonen
Journal:  Eur Spine J       Date:  2005-02-19       Impact factor: 3.134

4.  Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA.

Authors:  D Palfrey; P J Cook; J A Smythe; G Y Lip; A V Hine
Journal:  Mol Pathol       Date:  1999-10

Review 5.  Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Authors:  I W Fong
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

6.  Respiratory disease and cardiovascular morbidity.

Authors:  R-S Koskela; P Mutanen; J-A Sorsa; M Klockars
Journal:  Occup Environ Med       Date:  2005-09       Impact factor: 4.402

7.  Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism.

Authors:  P J Kraml; K Roubalová; M Bulvas; Z Sommerová; J PotoCková; V Mandys; M Andel
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

8.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

Review 9.  [Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences].

Authors:  M Maass
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

10.  The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women.

Authors:  M Koziołek; B Krzyzanowska-Swiniarska; I Maczyńska; T Miazgowski; S Giedrys-Kalemba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.